Susan Hasty, Publisher
Table of Contents . . . June 10th, 2002
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Hepatitis Weekly | Other Publications
Cirrhosis - HLA compatibility impacts outcomes in hepatitis B related liver transplantation
Coinfection - Protease inhibitors may reduce hepatitis C load in people coinfected with HIV
Chronic Hepatitis B - Combination of vaccine and antiviral fractures immune tolerance in virus model
Combination Therapy - RNA levels at 12 weeks best indicator for sustained response in hepatitis C
Osteoporosis - Vitamin K-2 prevents bone loss in women with cirrhosis
End-stage Liver Disease - Potential therapy reported for children, adults
Finance - First quarter net loss: $0.09 per share
Hepatitis B - Company reveals new aspects of mechanism of action for HspE7
Hepatitis C - Data on peginterferon alfa-2a presented at digestive disease conference
Liver Cancer - New treatment reduces tumors and improves quality of life for patients
Mergers and Acquisitions - Dimethaid Research completes purchase agreement for Oxo Chemie AG
Mergers and Acquisitions - Dragon Acquires Remainder of Nanjing Huaxin Biopharmaceutical Co.
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.